October 9, 2019

Successfully Addressing the Challenges of Glycosylation

Post-translational modification is a critical step in the synthesis of biotherapeutic molecules. Among these alterations to the original naked protein, glycosylation may be the most significant and difficult to properly complete. In this roundtable, we ...

Continue Reading

July 25, 2019

Reducing Fill-Finish Wait Times

iBio has expanded its CDMO service offerings to include independent sterile liquid cGMP fill-finish services to support the preclinical and clinical trial needs of drug developers. This new service complements iBio’s existing biologics bulk drug ...

Continue Reading

May 30, 2019

The Advantage of Plant-based Expression Solutions Around the Globe

iBio offers development and manufacturing services for biologic drug substances and drug products, built around our proprietary plant-based platform technology. Client support is offered from early development through fill and finish for research-grade, ...

Continue Reading

May 24, 2019

Plant-Based Protein Expression for Rapid, Green Bioprocessing

Mammalian cell culture is widely used for biologic drug substance production, but the high cost and long development times pose challenges to the implementation of this technology in many parts of the world. Traditional protein expression systems are ...

Continue Reading

February 22, 2019

Divine Outsourcing Model for Biotechs

Imagine you work at a virtual biopharma with a highly specialized biopharmaceutical ready for advanced development. You contact the one CDMO that you’ve been told undoubtedly has the most experience in your field.

Continue Reading
1 2 3